tiprankstipranks
Petros Pharmaceuticals (PTPI)
OTHER OTC:PTPI
US Market
PTPI
Petros Pharmaceuticals
RESEARCH TOOLSreports

Petros Pharmaceuticals (PTPI) Income Statement

200 Followers

Petros Pharmaceuticals Income Statement

Last quarter (Q1 2026), Petros Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Petros Pharmaceuticals's net income was $-987.04K. See Petros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 5.11M$ 5.82M$ 5.99M$ 7.81M
Gross Profit
$ 0.00$ 3.90M$ 4.19M$ 3.70M$ 6.21M
Operating Expenses
$ 4.64M$ 21.58M$ 17.81M$ 23.62M$ 24.26M
Depreciation and Amortization
$ 0.00$ 2.94M$ 3.42M$ 5.72M$ 6.88M
EBITDA
$ -4.64M$ -10.81M$ -4.21M$ -13.73M$ -1.74M
Operating Income
$ -4.64M$ -17.68M$ -13.62M$ -19.92M$ -18.05M
Other Income/Expenses
$ 141.31K$ 3.36M$ 5.45M$ -121.82K$ 9.06M
Pretax Income
$ -4.50M$ -14.32M$ -8.16M$ -20.04M$ -8.99M
Net Income
$ 1.91M$ -14.32M$ -8.16M$ -20.04M$ -8.99M
Per Share Metrics
Basic EPS
$ -1.56$ -3.34$ -6.35$ -9.68$ -8.25
Diluted EPS
$ -1.56$ -3.34$ -6.35$ -9.68$ -8.25
Weighted Average Shares Outstanding
 280.65M 8.03M 1.29M 2.07M 1.09M
Weighted Average Shares Outstanding (Diluted)
 280.65M 8.03M 2.18M 2.07M 1.09M
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History